BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28270295)

  • 1. Expressions of Immune Negative Regulator FoxP3+Treg and PD-L1 Protein in the Immune Microenvironment of Cervical Lesion.
    Ma Q; Zhao M; Wei X; Zhao J; Yang T; Zhang Q; Wang K; Yang X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Feb; 39(1):128-132. PubMed ID: 28270295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-L1
    Zhou L; Wang J; Lyu SC; Pan LC; Shi XJ; Du GS; He Q
    Technol Cancer Res Treat; 2021; 20():15330338211045820. PubMed ID: 34605709
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune-checkpoint status in penile squamous cell carcinoma: a North American cohort.
    Cocks M; Taheri D; Ball MW; Bezerra SM; Del Carmen Rodriguez M; Ricardo BFP; Bivalacqua TJ; Sharma RB; Meeker A; Chaux A; Burnett AL; Netto GJ
    Hum Pathol; 2017 Jan; 59():55-61. PubMed ID: 27663086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant Expressions of Immune Factors Facilitate the Disequilibrium of Immune Status in Cervical Cancer.
    Zhao MY; Zhao J; Yang T; Wang L; Pei ML; Tian SJ; Yu Y; Yang XF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):522-527. PubMed ID: 27825407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of indoleamine 2, 3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer.
    Nakamura T; Shima T; Saeki A; Hidaka T; Nakashima A; Takikawa O; Saito S
    Cancer Sci; 2007 Jun; 98(6):874-81. PubMed ID: 17433037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nodal metastasis in cervical cancer occurs in clearly delineated fields of immune suppression in the pelvic lymph catchment area.
    Heeren AM; de Boer E; Bleeker MC; Musters RJ; Buist MR; Kenter GG; de Gruijl TD; Jordanova ES
    Oncotarget; 2015 Oct; 6(32):32484-93. PubMed ID: 26431490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-L1 Expression Level Displays a Positive Correlation with Immune Response in Pancreatic Cancer.
    Zhao L; Cao Y
    Dis Markers; 2020; 2020():8843146. PubMed ID: 33062072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical Analysis of Foxp3
    Stasikowska-Kanicka O; WÄ…growska-Danilewicz M; Danilewicz M
    Pathol Oncol Res; 2018 Jul; 24(3):497-505. PubMed ID: 28669079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmed death 1/programmed cell death-ligand 1 pathway participates in gastric surgery-induced imbalance of T-helper 17/regulatory T cells in mice.
    Dong L; Zheng X; Wang K; Wang G; Zou H
    J Trauma Acute Care Surg; 2018 Sep; 85(3):549-559. PubMed ID: 29554041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour immune microenvironment in primary and metastatic papillary renal cell carcinoma.
    Eich ML; Chaux A; Mendoza Rodriguez MA; Guner G; Taheri D; Rodriguez Pena MDC; Sharma R; Allaf ME; Netto GJ
    Histopathology; 2020 Feb; 76(3):423-432. PubMed ID: 31494951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of EBI3 on radiation-induced immunosuppression of cervical cancer HeLa cells by regulating Treg cells through PD-1/PD-L1 pathway.
    Zhang SA; Niyazi HE; Hong W; Tuluwengjiang GL; Zhang L; Zhang Y; Su WP; Bao YX
    Tumour Biol; 2017 Mar; 39(3):1010428317692237. PubMed ID: 28351328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of cancer stem-like cell markers SOX2 and CD133 in stage III colon cancer is modified by expression of the immune-related markers FoxP3, PD-L1 and CD3.
    Miller TJ; McCoy MJ; Hemmings C; Bulsara MK; Iacopetta B; Platell CF
    Pathology; 2017 Dec; 49(7):721-730. PubMed ID: 29102042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the combination of sintilimab and chemotherapy on the tumor and paratumor PD-L1, IDO, TIM-3, FOXP3+ and CD8 expressions in patients with advanced esophageal squamous cell carcinoma.
    Zhang S; Cai H; Huang J; Wang G
    Thorac Cancer; 2022 Dec; 13(23):3284-3294. PubMed ID: 36288460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro effect of pembrolizumab on different T regulatory cell subsets.
    Toor SM; Syed Khaja AS; Alkurd I; Elkord E
    Clin Exp Immunol; 2018 Feb; 191(2):189-197. PubMed ID: 28963773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. anlotinib alters tumor immune microenvironment by downregulating PD-L1 expression on vascular endothelial cells.
    Liu S; Qin T; Liu Z; Wang J; Jia Y; Feng Y; Gao Y; Li K
    Cell Death Dis; 2020 May; 11(5):309. PubMed ID: 32366856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High and interrelated rates of PD-L1+CD14+ antigen-presenting cells and regulatory T cells mark the microenvironment of metastatic lymph nodes from patients with cervical cancer.
    Heeren AM; Koster BD; Samuels S; Ferns DM; Chondronasiou D; Kenter GG; Jordanova ES; de Gruijl TD
    Cancer Immunol Res; 2015 Jan; 3(1):48-58. PubMed ID: 25361854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different pattern of PD-L1, IDO, and FOXP3 Tregs expression with survival in thymoma and thymic carcinoma.
    Wei YF; Chu CY; Chang CC; Lin SH; Su WC; Tseng YL; Lin CC; Yen YT
    Lung Cancer; 2018 Nov; 125():35-42. PubMed ID: 30429036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in PD-L1-Expressing Macrophages and Immune Microenvironment in Testicular Germ Cell Tumors.
    Sadigh S; Farahani SJ; Shah A; Vaughn D; Lal P
    Am J Clin Pathol; 2020 Feb; 153(3):387-395. PubMed ID: 31802108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-L1 signal on liver dendritic cells is critical for Foxp3(+)CD4(+)CD25(+) Treg and liver tolerance induction in mice.
    Liu H; Bakthavatsalam R; Meng Z; Li Z; Li W; Perkins JD; Reyes J
    Transplant Proc; 2013 Jun; 45(5):1853-5. PubMed ID: 23769057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of PD-1/PD-L1 on immune microenvironment in oral leukoplakia and oral squamous cell carcinoma.
    Xu SB; Wang MY; Shi XZ; Wang Q; Yu M; Zhang W; Xu XH; Liu LK
    Oral Dis; 2023 Nov; 29(8):3268-3277. PubMed ID: 35921211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.